CLINICAL STUDIES

 
Islet Allotransplantation for patients with T1DM

A Safety, Tolerability and Efficacy Study of Sernova’s Cell Pouch™  for Clinical Islet Transplantation.

Funded by JDRF/Sernova

OPEN ENROLLMENT

Islet Transplantation in Patients with “Brittle” Type 1 Diabetes

 

Internal Funding 

Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients

 

Internal Funding 

COMPLETED

RESULTS >>

Allogenic Islet Cells (Human. U. of Chicago) Administered via Intraportal Infusion and Immunosuppressive Therapy.

Funded by the State of Illinois

COMPLETED

A Phase 3, Multicenter, Randomized, Double-blind, Parallel Assignment Study to Assess The Efficacy and Safety of Reparixin in Pancreatic Islet Transplantation (REP0211).

Funded by DOMPE Pharmaceutical.. 

CONTACT:

 

 

 

 

 

 

 

 

Transplantation Institute

Clinical  Research Center

 

Islet and Kidney Transplantation

Manager, Lindsay Basto RN MSN 

Lindsay.Basto@uchospitals.edu

tel. (773) 702-2504

fax (773) 926-0671

 

Islet and Cell Processing and Research

Manager, Karolina Golab, PhD

kgolab@surgery.bsd.uchicago.edu


Transplantation Institute

University of Chicago Medicine

5841 S. Maryland Avenue

MC 5026, J-517

Chicago IL 60637

Polish-American Transplant Center

Clinical Coordinator

Patrycja Ulijaszyk RN 

Patrycja.Ulijaszyk@uchospitals.edu

  • Facebook - Grey Circle
  • Twitter - Grey Circle

© 2018 by Kajetan Witkowski